Generic Labeling “Carve-Outs” For Marinol Challenged On Safety Grounds
Solvay is asking FDA to prevent generic companies from using the "little eight" carve-out in their ANDAs for Marinol (dronabinol)
Solvay is asking FDA to prevent generic companies from using the "little eight" carve-out in their ANDAs for Marinol (dronabinol)